BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

25 related articles for article (PubMed ID: 24789922)

  • 1. 1-Laurin-3-Palmitin as a Novel Matrix of Solid Lipid Particles: Higher Loading Capacity of Thymol and Better Stability of Dispersions Than Those of Glyceryl Monostearate and Glyceryl Tripalmitate.
    Shi H; Huang S; He J; Han L; Zhang W; Zhong Q
    Nanomaterials (Basel); 2019 Mar; 9(4):. PubMed ID: 30934814
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New surface-modified solid lipid nanoparticles using N-glutaryl phosphatidylethanolamine as the outer shell.
    Kashanian S; Azandaryani AH; Derakhshandeh K
    Int J Nanomedicine; 2011; 6():2393-401. PubMed ID: 22114489
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transdermal Anti-Inflammatory Delivery for Solid Lipid Nanoparticles of Ketoprofen by Microwave-Assisted Microemulsion.
    Jagdale SC; Bafna MS; Chabukswar AR
    Recent Adv Inflamm Allergy Drug Discov; 2022 Jan; ():. PubMed ID: 35081901
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Solid Lipid Nanoparticles Containing Dopamine and Grape Seed Extract: Freeze-Drying with Cryoprotection as a Formulation Strategy to Achieve Nasal Powders.
    De Giglio E; Bakowsky U; Engelhardt K; Caponio A; La Pietra M; Cometa S; Castellani S; Guerra L; Fracchiolla G; Poeta ML; Mallamaci R; Cardone RA; Bellucci S; Trapani A
    Molecules; 2023 Nov; 28(23):. PubMed ID: 38067437
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Solid Lipid Nanoparticles for Dibucaine Sustained Release.
    de M Barbosa R; Ribeiro LNM; Casadei BR; da Silva CMG; Queiróz VA; Duran N; de Araújo DR; Severino P; de Paula E
    Pharmaceutics; 2018 Nov; 10(4):. PubMed ID: 30441802
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development and Statistical Optimization of Solid Lipid Nanoparticle Formulations of Fluticasone Propionate.
    Amasya G; Şengel TÜrk CT; Badilli U; Tarimci N
    Turk J Pharm Sci; 2020 Aug; 17(4):359-366. PubMed ID: 32939130
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Physicochemical Characteristics and In Vitro Toxicity/Anti-SARS-CoV-2 Activity of Favipiravir Solid Lipid Nanoparticles (SLNs).
    Tulbah AS; Lee WH
    Pharmaceuticals (Basel); 2021 Oct; 14(10):. PubMed ID: 34681283
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Liposomal Formulation for Improving Solubility and Oral Bioavailability of Nifedipine.
    Bi Y; Lv B; Li L; Lee RJ; Xie J; Qiu Z; Teng L
    Molecules; 2020 Jan; 25(2):. PubMed ID: 31947655
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nanomedicine strategies to improve therapeutic agents for the prevention and treatment of preterm birth and future directions.
    Taylor J; Sharp A; Rannard SP; Arrowsmith S; McDonald TO
    Nanoscale Adv; 2023 Mar; 5(7):1870-1889. PubMed ID: 36998665
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preparation, Statistical Optimization and
    Mehrabani Yeganeh E; Bagheri H; Mahjub R
    Iran J Pharm Res; 2020; 19(3):45-62. PubMed ID: 33680009
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combination of Roll Grinding and High-Pressure Homogenization Can Prepare Stable Bicelles for Drug Delivery.
    Matsuo S; Higashi K; Moribe K; Kimura SI; Itai S; Kondo H; Iwao Y
    Nanomaterials (Basel); 2018 Dec; 8(12):. PubMed ID: 30513913
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drug retention and stability of solid lipid nanoparticles containing azidothymidine palmitate after autoclaving, storage and lyophilization.
    Heiati H; Tawashi R; Phillips NC
    J Microencapsul; 1998; 15(2):173-84. PubMed ID: 9532523
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization and stability of nanostructured lipid carriers as drug delivery system.
    Abbasalipourkabir R; Salehzadeh A; Abdullah R
    Pak J Biol Sci; 2012 Feb; 15(3):141-6. PubMed ID: 22866544
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Optimization of the lyophilization process for long-term stability of solid-lipid nanoparticles.
    Howard MD; Lu X; Jay M; Dziubla TD
    Drug Dev Ind Pharm; 2012 Oct; 38(10):1270-9. PubMed ID: 22235767
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetic and pharmacodynamic studies of nisoldipine-loaded solid lipid nanoparticles developed by central composite design.
    Dudhipala N; Veerabrahma K
    Drug Dev Ind Pharm; 2015; 41(12):1968-77. PubMed ID: 25830370
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of highly stable nifedipine solid-lipid nanoparticles.
    Barman RK; Iwao Y; Funakoshi Y; Ranneh AH; Noguchi S; Wahed MI; Itai S
    Chem Pharm Bull (Tokyo); 2014; 62(5):399-406. PubMed ID: 24789922
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Naringenin-loaded solid lipid nanoparticles: preparation, controlled delivery, cellular uptake, and pulmonary pharmacokinetics.
    Ji P; Yu T; Liu Y; Jiang J; Xu J; Zhao Y; Hao Y; Qiu Y; Zhao W; Wu C
    Drug Des Devel Ther; 2016; 10():911-25. PubMed ID: 27041995
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.